Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, held its first Annual Meeting of Stockholders virtually on August 31, 2026. Shareholders approved several proposals that could significantly alter the company's capital structure and governance, marking a pivotal step in its quest to uplist to a national exchange such as Nasdaq or NYSE.
Among the approved measures, shareholders authorized the Board of Directors to pursue a reverse stock split if necessary to meet the bid price requirements for an uplisting. The authorization is valid for 12 months, giving the Board flexibility to act when market conditions are favorable. CEO and Chairman Giorgio R. Saumat emphasized that he will not support a reverse split unless it is clearly required for the uplisting. A reverse split would reduce the number of outstanding shares, typically increasing the stock price, which is a common prerequisite for meeting exchange listing standards.
In addition, stockholders authorized the Board's Independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This move would eliminate the company's current dual-class voting structure, simplifying its governance and potentially making it more attractive to institutional investors. The retirement of the Series B Preferred Stock could also reduce the influence of certain insiders, aligning the company's structure with those of many publicly traded peers.
Shareholders also ratified the appointment of Semple, Marchal & Cooper LLP as an independent registered public accounting firm, re-elected seven director nominees, and authorized a new non-dilutive executive compensation framework. The new compensation structure is designed to align executive incentives with shareholder interests without issuing additional shares, which could dilute existing holdings. These approvals reflect strong shareholder confidence in the company's leadership and strategic direction.
The decisions come as Earth Science Tech seeks to elevate its profile in the capital markets. An uplisting to a national exchange would enhance liquidity, broaden the investor base, and increase the company's visibility. The retirement of the Series B Preferred Stock would also streamline decision-making, potentially accelerating strategic initiatives in the healthcare and telemedicine sectors. As a holding company, ETST focuses on acquiring and growing businesses in these high-demand areas, and a stronger stock could provide currency for future acquisitions.
For investors, the approved proposals signal a clear commitment to enhancing shareholder value and achieving a higher market valuation. By authorizing a reverse split and simplifying its capital structure, ETST is positioning itself to meet the rigorous standards of national exchanges. The company's newsroom at https://ibn.fm/ETST offers ongoing updates on these developments. Additionally, details of the meeting were reported by InvestorWire, available at https://ibn.fm/HIqJ9.
The successful vote underscores shareholder alignment with management's vision. As ETST advances toward potential national exchange listing, the implications for its market presence and growth trajectory are substantial. The coming months will reveal whether the Board exercises the reverse split authorization and successfully negotiates the retirement of the Series B Preferred Stock, but the groundwork has been laid for a transformative period.
